{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:37:51Z","timestamp":1774712271892,"version":"3.50.1"},"reference-count":146,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.yexcr.2023.113618","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T01:34:17Z","timestamp":1682991257000},"page":"113618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Liver organoids as a primary human model to study HBV-mediated Hepatocellular carcinoma. A review"],"prefix":"10.1016","volume":"428","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3269-0099","authenticated-orcid":false,"given":"Simran","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preety","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savneet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha","family":"Puria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2023.113618_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2018.00261","article-title":"Host and viral genetic variation in HBV-related hepatocellular carcinoma","volume":"9","author":"An","year":"2018","journal-title":"Front. Genet."},{"issue":"2021","key":"10.1016\/j.yexcr.2023.113618_bib2","first-page":"19","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","volume":"22","author":"Iannacone","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2023.113618_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01328-21","article-title":"Long-term hepatitis B virus infection induces cytopathic effects in primary human hepatocytes, and can Be partially reversed by antiviral therapy","volume":"10","author":"Zai","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.yexcr.2023.113618_bib4","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","article-title":"Stealth and cunning: hepatitis B and hepatitis C viruses","volume":"79","author":"Wieland","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib5","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v20.i35.12462","article-title":"Potential mechanisms of hepatitis B virus induced liver injury","volume":"20","author":"Suhail","year":"2014","journal-title":"World J. Gastroenterol. : WJG."},{"key":"10.1016\/j.yexcr.2023.113618_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(20)32657-X","article-title":"Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study","volume":"397","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2023.113618_bib7","first-page":"434","volume":"14","author":"Chien","year":"2022","journal-title":"Current Trend in Antiviral Therapy for Chronic Hepatitis B, Viruses"},{"key":"10.1016\/j.yexcr.2023.113618_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s15010-019-01345-y","article-title":"Epidemiological and etiological variations in hepatocellular carcinoma","volume":"48","author":"Sagnelli","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.yexcr.2023.113618_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrgastro.2016.37","article-title":"Experimental models of hepatitis B and C \u2014 new insights and progress","volume":"13","author":"Thomas","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexcr.2023.113618_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2023.113618_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0022-2836(83)80274-5","article-title":"Core and E antigen synthesis in rodent cells transformed with hepatitis B virus DNA is associated with greater than genome length viral messenger RNAs","volume":"165","author":"Gough","year":"1983","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.yexcr.2023.113618_bib13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nature10450","article-title":"Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT","volume":"478","author":"Hu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2023.113618_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/v9060156","article-title":"The role of cccDNA in HBV maintenance","volume":"9","author":"Allweiss","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.yexcr.2023.113618_bib15","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/j.1460-2075.1994.tb06353.x","article-title":"A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis","volume":"13","author":"Ostapchuk","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2023.113618_bib16","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2016.09.11","article-title":"Diagnosis of hepatitis B","volume":"4","author":"Song","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.yexcr.2023.113618_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/17474124.2.4.553","article-title":"Diagnosis of hepatitis B virus infection through serological and virological markers","volume":"2","author":"Kao","year":"2008","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexcr.2023.113618_bib18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/BF01318693","article-title":"Clinical significance of concurrent hepatitis B surface antigen and antibody positivity","volume":"31","author":"Tsang","year":"1986","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.yexcr.2023.113618_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14737159.5.1.75","article-title":"Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene","volume":"5","author":"Weber","year":"2005","journal-title":"Expert Rev. Mol. Diagn"},{"key":"10.1016\/j.yexcr.2023.113618_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","article-title":"Occult hepatitis B virus infection","volume":"46","author":"Raimondo","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2023.113618_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a021469","article-title":"The chimpanzee model for hepatitis B virus infection","volume":"5","author":"Wieland","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.yexcr.2023.113618_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/eji.1830270315","article-title":"Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance","volume":"27","author":"Vitiello","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yexcr.2023.113618_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinids\/2.3.470","article-title":"Type B hepatitis: a review of current prospects for a safe and effective vaccine","volume":"2","author":"McAuliffe","year":"1980","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.yexcr.2023.113618_bib24","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.23602","article-title":"Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model","volume":"51","author":"Lucifora","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2023.113618_bib25","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1099\/0022-1317-83-7-1645","article-title":"Experimental transfection of Macaca sylvanus with cloned human hepatitis B virus","volume":"83","author":"Gheit","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01953-y","article-title":"Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques","volume":"8","author":"Burwitz","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2023.113618_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-015-0256-x","article-title":"Chronic hepatitis B virus infection and occurrence of hepatocellular carcinoma in tree shrews (Tupaia belangeri chinensis)","volume":"12","author":"Yang","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.yexcr.2023.113618_bib28","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1128\/JVI.77.17.9511-9521.2003","article-title":"Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus","volume":"77","author":"Glebe","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.yexcr.2023.113618_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021352","article-title":"Animal models and the molecular biology of hepadnavirus infection","volume":"5","author":"Mason","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.yexcr.2023.113618_bib31","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/347294a0","article-title":"Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours","volume":"347","author":"Fourel","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2023.113618_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003856","article-title":"Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection","volume":"10","author":"Liu","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.yexcr.2023.113618_bib33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(82)90157-X","article-title":"Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate","volume":"29","author":"Summers","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2023.113618_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(86)90602-1","article-title":"Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells","volume":"47","author":"Tuttleman","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2023.113618_bib35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2016.05.043","article-title":"Aiming for cure in HBV and HDV infection","volume":"65","author":"Petersen","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2023.113618_bib36","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/j.gastro.2012.03.006","article-title":"Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice","volume":"142","author":"Huang","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2023.113618_bib37","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","article-title":"High-level hepatitis B virus replication in transgenic mice","volume":"69","author":"Guidotti","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/351317a0","article-title":"HBx gene of hepatitis B virus induces liver cancer in transgenic mice","volume":"351","author":"Kim","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2023.113618_bib39","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1038\/emi.2013.10","article-title":"Hepatitis B virus genetic variants: biological properties and clinical implications","volume":"2","author":"Tong","year":"2013","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.yexcr.2023.113618_bib40","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","article-title":"High-level hepatitis B virus replication in transgenic mice","volume":"69","author":"Guidotti","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib41","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/sj.mt.6300314","article-title":"Hydrodynamic gene delivery: its principles and applications","volume":"15","author":"Suda","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2023.113618_bib42","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1073\/pnas.202398599","article-title":"Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection","volume":"99","author":"Yang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2023.113618_bib43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nbt824","article-title":"Inhibition of hepatitis B virus in mice by RNA interference","volume":"21","author":"McCaffrey","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2023.113618_bib44","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jhep.2016.02.012","article-title":"Experimental in vitro and in vivo models for the study of human hepatitis B virus infection","volume":"64","author":"Allweiss","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2023.113618_bib45","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/acsinfecdis.8b00223","article-title":"Vivo model systems for hepatitis B virus research","volume":"5","author":"Ortega-Prieto","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.yexcr.2023.113618_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-981-13-9151-4_5","article-title":"Cell culture models and animal models for HBV study","volume":"1179","author":"Li","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.yexcr.2023.113618_bib47","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1128\/JVI.01024-14","article-title":"Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice","volume":"88","author":"Qi","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100252","article-title":"A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome","volume":"3","author":"Kruse","year":"2021","journal-title":"JHEP Reports"},{"key":"10.1016\/j.yexcr.2023.113618_bib49","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2893.2010.01302.x","article-title":"Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B","volume":"18","author":"John Von Freyend","year":"2011","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.yexcr.2023.113618_bib50","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021477","article-title":"Mouse models of hepatitis B virus pathogenesis","volume":"5","author":"Iannacone","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.yexcr.2023.113618_bib51","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.3389\/fimmu.2021.766534","article-title":"Vivo mouse models for hepatitis B virus infection and their application","volume":"12","author":"Du","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2023.113618_bib52","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0092-8674(90)90010-C","article-title":"Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator","volume":"62","author":"Heckel","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2023.113618_bib53","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fimmu.2021.638447","article-title":"Establishment of humanized mice for the study of HBV","volume":"12","author":"Lai","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2023.113618_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002255","article-title":"Secretion of genome-free hepatitis B virus--single strand blocking model for virion morphogenesis of para-retrovirus","volume":"7","author":"Ning","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.yexcr.2023.113618_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0092-8674(86)90364-8","article-title":"Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA","volume":"47","author":"Sureau","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2023.113618_bib56","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1073\/pnas.84.13.4641","article-title":"Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees","volume":"84","author":"Acs","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2023.113618_bib57","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2023.113618_bib58","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1073\/pnas.84.2.444","article-title":"Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA","volume":"84","author":"Tsurimoto","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2023.113618_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3748\/wjg.v5.i4.289","article-title":"Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA","volume":"5","author":"Lee","year":"1999","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.yexcr.2023.113618_bib60","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yexcr.2023.113618_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00922-20","article-title":"Characterization of the termini of cytoplasmic hepatitis B virus deproteinated relaxed circular DNA","volume":"95","author":"Cai","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2006.05.006","article-title":"Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays","volume":"72","author":"Zhou","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.yexcr.2023.113618_bib63","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1128\/JVI.79.3.1813-1823.2005","article-title":"Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method","volume":"79","author":"Chou","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib64","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/JVI.01263-15","article-title":"Viral DNA-dependent induction of innate immune response to hepatitis B virus in immortalized mouse hepatocytes","volume":"90","author":"Cui","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.23230","article-title":"Control of hepatitis B virus replication by innate response of HepaRG cells","volume":"51","author":"Lucifora","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2023.113618_bib66","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hep.29609","article-title":"Hepatitis B virus sensitivity to interferon-\u03b1 in hepatocytes is more associated with cellular interferon response than with viral genotype","volume":"67","author":"Shen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2023.113618_bib67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1099\/vir.0.004861-0","article-title":"Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells","volume":"90","author":"Hantz","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib68","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00539-17","article-title":"Identification of an intermediate in hepatitis B virus covalently closed circular (CCC) DNA formation and sensitive and selective CCC DNA detection","volume":"91","author":"Luo","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib69","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01771-17","article-title":"Silencing retinoid X receptor alpha expression enhances early-stage hepatitis B virus infection in cell cultures","volume":"92","author":"Song","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib70","article-title":"Distribution of hepatitis B virus nuclear DNA","volume":"92","author":"Li","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib71","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/0016-5085(94)90700-5","article-title":"In vitro experimental infection of primary human hepatocytes with hepatitis B virus","volume":"106","author":"Galle","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2023.113618_bib72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2893.1996.tb00048.x","article-title":"Long-term productive episomal hepatitis B virus replication in primary cultures of adult human hepatocytes infected in vitro","volume":"3","author":"Rumin","year":"1996","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.yexcr.2023.113618_bib73","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jviromet.2013.10.010","article-title":"Long-term maintenance of human fetal hepatocytes and prolonged susceptibility to HBV infection by co-culture with non-parenchymal cells","volume":"195","author":"Zhou","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.yexcr.2023.113618_bib74","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1073\/pnas.1412631111","article-title":"Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems","volume":"111","author":"Shlomai","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2023.113618_bib75","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2016.10.009","article-title":"Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions","volume":"66","author":"Xia","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2023.113618_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/srep29358","article-title":"Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus","volume":"6","author":"Kaneko","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2023.113618_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001082","article-title":"Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner","volume":"6","author":"K\u00f6ck","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.yexcr.2023.113618_bib78","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of hepatitis B virus at the level of transcription","volume":"17","author":"Quasdorff","year":"2010","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.yexcr.2023.113618_bib79","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1073\/pnas.98.4.1841","article-title":"Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism","volume":"98","author":"Tang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2023.113618_bib80","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.29112","article-title":"Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes","volume":"66","author":"Lempp","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2023.113618_bib81","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1128\/JVI.01261-15","article-title":"Hepatitis B virus covalently closed circular DNA formation in immortalized mouse hepatocytes associated with nucleocapsid destabilization","volume":"89","author":"Cui","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib82","doi-asserted-by":"crossref","first-page":"11494","DOI":"10.1128\/JVI.01912-13","article-title":"Maturation-associated destabilization of hepatitis B virus nucleocapsid","volume":"87","author":"Cui","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib83","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1128\/JVI.02832-15","article-title":"Hepatitis B virus infection of a mouse hepatic cell line reconstituted with human sodium taurocholate cotransporting polypeptide","volume":"90","author":"Lempp","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004840","article-title":"Hepatitis D virus infection of mice expressing human sodium taurocholate Co-transporting polypeptide","volume":"11","author":"He","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.yexcr.2023.113618_bib85","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2018.06.093","article-title":"Cell and animal models for studying hepatitis B virus infection and drug development","volume":"156","author":"Hu","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2023.113618_bib86","article-title":"Organoids to model liver disease","volume":"3","author":"Nuciforo","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.yexcr.2023.113618_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a021469","article-title":"The chimpanzee model for hepatitis B virus infection","volume":"5","author":"Wieland","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.yexcr.2023.113618_bib120","first-page":"144","article-title":"An oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees","author":"Lanford","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2023.113618_bib121","first-page":"127","article-title":"Tree shrew (Tupaia belangeri) as a novel laboratory disease animal model","volume":"38","author":"Xiao","year":"2017","journal-title":"Zool. Res."},{"key":"10.1016\/j.yexcr.2023.113618_bib122","first-page":"660","article-title":"The tree shrew as a model for cancer research","volume":"11","author":"Lu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2023.113618_bib123","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1128\/jvi.36.3.829-836.1980","article-title":"Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus","volume":"36","author":"Mason","year":"1980","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib124","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.29737","article-title":"Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks","volume":"67","author":"Quinet","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2023.113618_bib125","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1073\/pnas.75.9.4533","article-title":"A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks","volume":"75","author":"Summers","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2023.113618_bib126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3748\/wjg.v13.i1.104","article-title":"The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection","volume":"13","author":"Menne","year":"2007","journal-title":"World J. Gastroenterol. : WJG"},{"key":"10.1016\/j.yexcr.2023.113618_bib127","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2017.10.017","article-title":"Efficacy of NVR 3-778, alone and in combination with pegylated interferon, vs entecavir in uPA\/SCID mice with humanized livers and HBV infection","volume":"154","author":"Klumpp","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2023.113618_bib128","doi-asserted-by":"crossref","DOI":"10.1039\/C9RA06383H","article-title":"Divergent synthesis of a thiolate-based \u03b1-hydroxytropolone library with a dynamic bioactivity profile","volume":"9","author":"Agyemang","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.yexcr.2023.113618_bib129","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","article-title":"High-level hepatitis B virus replication in transgenic mice","volume":"69","author":"Guidotti","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib130","first-page":"141","article-title":"5\u2019 Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice","author":"Ebert","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2023.113618_bib131","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/jvi.60.3.880-887.1986","article-title":"Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice","volume":"60","author":"V Chisari","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib132","first-page":"1316","article-title":"Hepatitis B virus transgenic mice: insights into the virus and the disease","volume":"22","author":"Chisari","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2023.113618_bib133","first-page":"142","article-title":"Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice","author":"Huang","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2023.113618_bib134","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hep.29406","article-title":"Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model","volume":"67","author":"Li","year":"2018","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.yexcr.2023.113618_bib135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jgh.12035","article-title":"Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses","volume":"28","author":"Tzeng","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexcr.2023.113618_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198224","article-title":"Cre\/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection","volume":"292","author":"Kruse","year":"2021","journal-title":"Virus Res."},{"key":"10.1016\/j.yexcr.2023.113618_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002255","article-title":"Secretion of genome-free hepatitis B virus--single strand blocking model for virion morphogenesis of para-retrovirus","volume":"7","author":"Ning","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.yexcr.2023.113618_bib138","article-title":"Antiviral compounds screening targeting HBx protein of the hepatitis B virus","volume":"23","author":"Ma","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2023.113618_bib139","first-page":"1","article-title":"Epithelial cell adhesion molecule in human hepatocellular carcinoma cell lines: a target of chemoresistence","volume":"16","author":"Li","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2023.113618_bib140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/iai.30.2.607-611.1980","article-title":"PLC\/PRF\/5 (Alexander) hepatoma cell line: further characterization and studies of infectivity","volume":"30","author":"Daemer","year":"1980","journal-title":"Infect. Immun."},{"key":"10.1016\/j.yexcr.2023.113618_bib141","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2023.113618_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001082","article-title":"Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner","volume":"6","author":"K\u00f6ck","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.yexcr.2023.113618_bib143","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2023.113618_bib144","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.yexcr.2023.113618_bib145","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/acsmedchemlett.9b00630","article-title":"P450s under restriction (PURE) screen using HepaRG and primary human hepatocytes for discovery of novel HBV antivirals","volume":"11","author":"Hartman","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.yexcr.2023.113618_bib146","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ebiom.2018.08.014","article-title":"Recapitulation of hepatitis B virus\u2013host interactions in liver organoids from human induced pluripotent stem cells","volume":"35","author":"Nie","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.yexcr.2023.113618_bib147","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60747","article-title":"Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma","volume":"10","author":"de Crignis","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.yexcr.2023.113618_bib87","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","article-title":"Progress and potential in organoid research","volume":"19","author":"Rossi","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yexcr.2023.113618_bib88","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13770-019-00178-y","article-title":"Stem cell-based therapies for liver diseases: an overview and update","volume":"16","author":"Wang","year":"2019","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.yexcr.2023.113618_bib89","first-page":"1","article-title":"Liver organoids, novel and promising modalities for exploring and repairing liver injury","author":"He","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.yexcr.2023.113618_bib90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41422-018-0103-x","article-title":"Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens","volume":"29","author":"Fu","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.yexcr.2023.113618_bib91","first-page":"146","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2023.113618_bib92","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60747","article-title":"Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma","volume":"10","author":"de Crignis","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.yexcr.2023.113618_bib93","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2021.02.024","article-title":"3D human liver organoids: an in vitro platform to investigate HBV infection, replication and liver tumorigenesis","volume":"506","author":"Rao","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2023.113618_bib94","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94954","article-title":"Human hepatic organoids for the analysis of human genetic diseases","volume":"2","author":"Guan","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.yexcr.2023.113618_bib95","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3748\/wjg.v13.i1.22","article-title":"Viral and cellular determinants involved in hepadnaviral entry","volume":"13","author":"Glebe","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.yexcr.2023.113618_bib96","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2023.113618_bib97","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2023.113618_bib98","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60747","article-title":"Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma","volume":"10","author":"De Crignis","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.yexcr.2023.113618_bib99","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ebiom.2018.08.014","article-title":"Recapitulation of hepatitis B virus\u2013host interactions in liver organoids from human induced pluripotent stem cells","volume":"35","author":"Nie","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.yexcr.2023.113618_bib100","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1074\/jbc.274.5.2858","article-title":"Interaction of hepatitis B viral X protein and CCAAT\/enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II\/pregenomic promoter","volume":"274","author":"Choi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2023.113618_bib101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.28013","article-title":"A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses","volume":"63","author":"Verrier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2023.113618_bib102","doi-asserted-by":"crossref","first-page":"11354","DOI":"10.1128\/JVI.75.23.11354-11364.2001","article-title":"Critical roles of nuclear receptor response elements in replication of hepatitis B virus","volume":"75","author":"Yu","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2023.113618_bib103","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2014.01.030","article-title":"Viral-human chimeric transcript predisposes risk to liver cancer development and progression","volume":"25","author":"Lau","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2023.113618_bib104","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"Shin","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2023.113618_bib105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ebiom.2018.08.014","article-title":"Recapitulation of hepatitis B virus\u2013host interactions in liver organoids from human induced pluripotent stem cells","volume":"35","author":"Nie","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.yexcr.2023.113618_bib106","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ebiom.2018.08.014","article-title":"Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells","volume":"35","author":"Nie","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.yexcr.2023.113618_bib107","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.celrep.2018.07.001","article-title":"Organoid models of human liver cancers derived from tumor needle biopsies","volume":"24","author":"Nuciforo","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.yexcr.2023.113618_bib108","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1158\/0008-5472.CAN-16-1559","article-title":"Integrative genomic analysis identifies the core transcriptional hallmarks of human hepatocellular carcinoma","volume":"76","author":"Allain","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2023.113618_bib109","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/jcp.26955","article-title":"MicroRNA-1271 functions as a potential tumor suppressor in hepatitis B virus-associated hepatocellular carcinoma through the AMPK signaling pathway by binding to CCNA1","volume":"234","author":"Chen","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexcr.2023.113618_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019862","article-title":"Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma","volume":"6","author":"Tao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2023.113618_bib111","first-page":"445","article-title":"CYP3A4 gene is a novel biomarker for predicting a poor prognosis in hepatocellular carcinoma","volume":"14","author":"Ashida","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.yexcr.2023.113618_bib112","doi-asserted-by":"crossref","first-page":"12538","DOI":"10.1073\/pnas.1209979109","article-title":"Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells","volume":"109","author":"Kajiwara","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2023.113618_bib113","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-017-0749-1","article-title":"Human liver organoids generated with single donor-derived multiple cells rescue mice from acute liver failure","volume":"9","author":"Nie","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.yexcr.2023.113618_bib114","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4358","article-title":"Generation, maintenance and HBV infection of human liver organoids","volume":"12","author":"Romal","year":"2022","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.yexcr.2023.113618_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-01968-w","article-title":"Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets","volume":"40","author":"Luo","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2023.113618_bib116","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2021.02.024","article-title":"3D human liver organoids: an in vitro platform to investigate HBV infection, replication and liver tumorigenesis","volume":"506","author":"Rao","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2023.113618_bib117","first-page":"1099","article-title":"Hepatic failure and lactic acidosis due to fialuridine (FIAU)","author":"Obin","year":"1995","journal-title":"an Investigational Nucleoside Analogue for Chronic Hepatitis B"},{"key":"10.1016\/j.yexcr.2023.113618_bib118","article-title":"A human liver organoid screening platform for DILI risk prediction","author":"Zhang","year":"2023","journal-title":"J. Hepatol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482723001659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482723001659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:45:39Z","timestamp":1757997939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482723001659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0014482723001659"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2023.113618","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver organoids as a primary human model to study HBV-mediated Hepatocellular carcinoma. A review","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2023.113618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113618"}}